Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 July 2026

View source ↗

Summary

PRAC meeting highlights include new safety information for desogestrel- and etonogestrel-containing contraceptives and for Litfulo (ruxolitinib) used to treat a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Desogestrel-containing contraceptives (desogestrel)
• Etonogestrel-containing contraceptives (etonogestrel)
• Litfulo (deucravacitinib)

Snippet

PRAC agrees new safety information on desogestrel- and etonogestrel-containing contraceptives and Litfulo, a medicine to treat alopecia areata